Advertisement

Clinical and Experimental Nephrology

, Volume 22, Issue 1, pp 159–166 | Cite as

The choice of comorbidity scoring system in Chinese peritoneal dialysis patients

  • Terry King-Wing Ma
  • Kai Ming Chow
  • Bonnie Ching-Ha Kwan
  • Jack Kit-Chung Ng
  • Wing-Fai Pang
  • Chi Bon Leung
  • Philip Kam-To Li
  • Cheuk Chun SzetoEmail author
Original article

Abstract

Background

Several comorbidity scoring systems have been developed and validated, mostly in western hemodialysis patients with a high risk of cardiovascular disease. The performance of comorbidity scoring, however, depends on the patient population. In this study, we determine the optimal comorbidity scoring system for predicting survival of incident Chinese PD patients.

Methods

We studied 461 incident PD patients. The performance of Charlson Comorbidity Index (CCI), Hemmelgarn score, and Liu score as the survival predictor was compared.

Results

The mean age was 57.7 ± 13.7 years. The median CCI, Hemmelgarn, and Liu scores were 4 [inter-quartile range (IQR) 2–5], 1 (IQR 0–2), and 4 (IQR 2–5), respectively. Patients were followed for 45.5 ± 33.0 months. All 3 comorbidity scores were predictors of patient survival by univariate analysis. After adjusting for confounding factors, CCI was the best predictor of patient survival among the 3 indices, with each point increase in CCI conferring 31% excess in mortality risk [95% confidence interval (CI) 21–41%, p < 0.001]. In contrast, each point increase in Liu score confers 20% excess in mortality risk (95% CI 13–27%, p < 0.001). Although the Hemmelgarn score is an independent predictor of patient survival, over 70% of patients score 0 or 1 by this system, limiting its role as a prognostic marker.

Conclusion

CCI should be the preferred method for quantifying comorbidity load in incident Chinese PD patients, and it is a good predictor of survival in this group of patients.

Keywords

Renal failure Cardiovascular disease Survival 

Notes

Compliance with ethical standards

Conflict of interest

This study was supported by the Chinese University of Hong Kong (CUHK) research accounts 6901031. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. CC Szeto receives research grant and consultancy from Baxter Healthcare. The authors declare no other conflicts of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee at which the studies were conducted and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the Clinical Research Ethics Committee of the Chinese University of Hong Kong (IRB Approval Number CREC-2008.276).

Informed consent

Written informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Bowling CB, O’Hare AM. Managing older adults with CKD: individualized versus disease-based approaches. Am J Kidney Dis. 2012;59:293–302.CrossRefPubMedGoogle Scholar
  2. 2.
    de Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity. a critical review of available methods. J Clin Epidemiol. 2003;56:221–9.CrossRefPubMedGoogle Scholar
  3. 3.
    Fried L, Bernardini J, Piraino B. Charlson Comorbidity Index as a predictor of outcomes in incident peritoneal dialysis patients. Am J Kidney Dis. 2001;37:337–42.CrossRefPubMedGoogle Scholar
  4. 4.
    Fried L, Bernardini J, Piraino B. Comparison of the Charlson Comorbidity Index and the Davies score as a predictor of outcomes in PD patients. Perit Dial Int. 2003;23:568–73.PubMedGoogle Scholar
  5. 5.
    Di Iorio B, Cillo N, Cirillo M, De Santo NG. Charlson Comorbidity Index is a predictor of outcomes in incident hemodialysis patients and correlates with phase angle and hospitalization. Int J Artif Organs. 2004;27:330–6.CrossRefPubMedGoogle Scholar
  6. 6.
    Davies SJ, Russell L, Bryan J, Phillips L, Russell GI. Comorbidity, urea kinetics, and appetite in continuous ambulatory peritoneal dialysis patients: their interrelationship and prediction of survival. Am J Kidney Dis. 1995;26:353–61.CrossRefPubMedGoogle Scholar
  7. 7.
    Khan IH, Catto GR, Edward N, Fleming LW, Henderson IS, MacLeod AM. Influence of coexisting disease on survival on renal-replacement therapy. Lancet. 1993;341:415–8.CrossRefPubMedGoogle Scholar
  8. 8.
    van Manen JG, Korevaar JC, Dekker FW, Boeschoten EW, Bossuyt PM. Krediet RT How to adjust for comorbidity in survival studies in ESRD patients: a comparison of different indices. Am J Kidney Dis. 2002;40:82–9.CrossRefPubMedGoogle Scholar
  9. 9.
    Miskulin DC, Martin AA, Brown R, Fink NE, Coresh J, Powe NR, Zager PG, Meyer KB, Levey AS. Predicting 1 year mortality in an outpatient haemodialysis population: a comparison of comorbidity instruments. Nephrol Dial Transplant. 2004;19:413–20.CrossRefPubMedGoogle Scholar
  10. 10.
    Hemmelgarn BR, Manns BJ, Quan H, Ghali WA. Adapting the Charlson Comorbidity Index for use in patients with ESRD. Am J Kidney Dis. 2003;42:125–32.CrossRefPubMedGoogle Scholar
  11. 11.
    Liu J, Huang Z, Gilbertson DT, Foley RN, Collins AJ. An improved comorbidity index for outcome analyses among dialysis patients. Kidney Int. 2010;77:141–51.CrossRefPubMedGoogle Scholar
  12. 12.
    Kwan BC, Szeto CC. Is peritoneal dialysis kinder for the heart? Perit Dial Int. 2011;31:135–7.PubMedGoogle Scholar
  13. 13.
    Twardowski ZJ, Nolph KD, Khanna R, Prowant BF, Ryan LP, Moore HL, Neilsen MP. Peritoneal equilibration test. Perit Dial Bull. 1987;7:138–47.Google Scholar
  14. 14.
    Mak TW, Cheung CK, Cheung CM, Leung CB, Lam CW, Lai KN. Interference of creatinine measurement in CAPD fluid was dependent on glucose and creatinine concentrations. Nephrol Dial Transplant. 1997;12:184–6.CrossRefPubMedGoogle Scholar
  15. 15.
    Krediet RT, Boeschoten EW, Zuyderhoudt FM, Strackee J, Arisz L. Simple assessment of the efficacy of peritoneal transport in continuous ambulatory peritoneal dialysis patients. Blood Purif. 1986;4:194–203.CrossRefPubMedGoogle Scholar
  16. 16.
    Nolph KD, Moore HL, Twardowski ZJ, Khanna R, Prowant B, Meyer M, Ponferrada L. Cross-sectional assessment of weekly urea and creatinine clearances in patients on continuous ambulatory peritoneal dialysis. ASAIO J. 1992;38:M139–42.CrossRefPubMedGoogle Scholar
  17. 17.
    Van Olden RW, Krediet RT, Struijk DG, Arisz L. Measurement of residual renal function in patients treated with continuous peritoneal dialysis. J Am Soc Nephrol. 1996;7:745–8.PubMedGoogle Scholar
  18. 18.
    Enia G, Sicuso C, Alati G, Zoccali C. Subjective global assessment of nutrition in dialysis patients. Nephrol Dial Transplant. 1993;8:1094–8.PubMedGoogle Scholar
  19. 19.
    Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH. A malnutrition inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2001;38:1251–63.CrossRefPubMedGoogle Scholar
  20. 20.
    Bergstrom J, Heimburger O, Lindholm B. Calculation of the protein equivalent of total nitrogen appearance from urea appearance. Which formulas should be used? Perit Dial Int. 1998;18:467–73.PubMedGoogle Scholar
  21. 21.
    Forbes GB, Brunining GJ. Urinary creatinine excretion and lean body mass. Am J Clin Nutr. 1976;29:1359–66.CrossRefPubMedGoogle Scholar
  22. 22.
    Wu PH, Lin YT, Lee TC, Lin MY, Kuo MC, Chiu YW, Hwang SJ, Chen HC. Predicting mortality of incident dialysis patients in Taiwan—a longitudinal population-based study. PLoS One. 2013;8:e61930.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Jang SH, Chea JW, Lee KB. Charlson Comorbidity Index using administrative database in incident PD patients. Clin Nephrol. 2010;73:204–9.CrossRefPubMedGoogle Scholar
  24. 24.
    Rattanasompattikul M, Feroze U, Molnar MZ, Dukkipati R, Kovesdy CP, Nissenson AR, Norris KC, Kopple JD, Kalantar-Zadeh K. Charlson comorbidity score is a strong predictor of mortality in hemodialysis patients. Int Urol Nephrol. 2012;44:1813–23.CrossRefPubMedGoogle Scholar
  25. 25.
    Ho YW, Chau KF, Choy BY, Fung KS, Cheng YL, Kwan TH, Wong PN, Lai WM, Yuen SK, Lo SH, Chan CK, Leung CB. Hong Kong renal registry report 2012. Hong Kong J Nephrol. 2013;15:28–43.CrossRefGoogle Scholar
  26. 26.
    Miskulin DC, Meyer KB, Martin AA, Fink NE, Coresh J, Powe NR, Klag MJ, Levey AS. Comorbidity and its change predict survival in incident dialysis patients. Am J Kidney Dis. 2003;41:149–61.CrossRefPubMedGoogle Scholar

Copyright information

© Japanese Society of Nephrology 2017

Authors and Affiliations

  • Terry King-Wing Ma
    • 1
  • Kai Ming Chow
    • 1
  • Bonnie Ching-Ha Kwan
    • 1
  • Jack Kit-Chung Ng
    • 1
  • Wing-Fai Pang
    • 1
  • Chi Bon Leung
    • 1
  • Philip Kam-To Li
    • 1
  • Cheuk Chun Szeto
    • 1
    Email author
  1. 1.Carol and Richard Yu Peritoneal Dialysis Research Centre, Department of Medicine and Therapeutics, Prince of Wales HospitalThe Chinese University of Hong KongShatinChina

Personalised recommendations